<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Healthcare industry BW</title>
    <description>Healthcare industry BW</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://www.gesundheitsindustrie-bw.de/en</link>
    <item>
      <title>Blood vessels guide immune cells to metastases</title>
      <description><![CDATA[It has long been suspected that endothelial cells play a key role in determining how the body’s immune system responds to tumors. Researchers at the DKFZ and the Medical Faculty Mannheim of Heidelberg University have now identified, in mouse studies, a specialized population of blood vessel lining endothelial cells that enable an effective immune defense against cancer metastases in the liver. ]]></description>
      <pubDate>Mon, 20 Jul 2026 18:25:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-guide-immune-cells-metastases</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-guide-immune-cells-metastases</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>NovoTags: AI-designed proteins help scientists see inside living cells</title>
      <description><![CDATA[Researchers have designed synthetic and inducible proteins that bind to bright fluorescent dyes with high specificity and affinity, significantly expanding the toolkit for multicolour imaging of proteins inside cells.]]></description>
      <pubDate>Fri, 17 Jul 2026 13:51:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/novotags-ai-designed-proteins-help-scientists-see-inside-living-cells</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/novotags-ai-designed-proteins-help-scientists-see-inside-living-cells</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New Findings on Acute Leukemias: Specific Mutations Provide Targets for More Targeted Therapies</title>
      <description><![CDATA[Researchers at the NCT Heidelberg and the German Cancer Research Center (DKFZ) have, for the first time, systematically determined how specific mutations promote acute myeloid leukemias. The results show why IDH1- and IDH2-mutated leukemias develop differently despite similar molecular mechanisms—and open up new approaches for diagnostics and targeted therapies.
]]></description>
      <pubDate>Thu, 16 Jul 2026 14:21:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-acute-leukemias-specific-mutations-provide-targets-more-targeted-therapies</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-acute-leukemias-specific-mutations-provide-targets-more-targeted-therapies</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Impact of Overweight on Cancer Risk May Be Significantly Underestimated</title>
      <description><![CDATA[Being overweight and obesity may contribute to significantly more cancer cases than previously thought. This is the conclusion reached by researchers at the German Cancer Research Center (DKFZ). Their analysis shows that when more accurate measures of body fat and methodological biases are considered, more than 10 percent of all cancer cases can be attributed to increased body weight - nearly twice as many as previous estimates suggested.]]></description>
      <pubDate>Thu, 16 Jul 2026 13:57:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/impact-overweight-cancer-risk-may-be-significantly-underestimated</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/impact-overweight-cancer-risk-may-be-significantly-underestimated</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Targeted genetic manipulation of signal transduction pathways in CAR T cells enhances anti-tumour potency</title>
      <description><![CDATA[Chimeric antigen receptor (CAR) T cell therapy has emerged as a highly promising treatment modality but has so far been used almost exclusively for advanced haematologic malignancies. Researchers at the iFIT cluster of excellence in Tübingen have now used CRISPR base-editing technology to introduce precise point mutations into key signalling pathways of CAR T cells, significantly enhancing their long-term persistence and anti-tumour potency.]]></description>
      <pubDate>Thu, 16 Jul 2026 08:19:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/news/targeted-genetic-manipulation-signal-transduction-pathways-car-t-cells-enhances-anti-tumour-potency</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/news/targeted-genetic-manipulation-signal-transduction-pathways-car-t-cells-enhances-anti-tumour-potency</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Steering the Formulation of Engineered Tissue by Sound Waves</title>
      <description><![CDATA[With the aid of physical forces it is possible to actively steer the formation of engineered tissue. For example, sound waves can be used to create functional vascular networks with blood vessel-like structures in vitro. Scientists at the Center for Molecular Biology of Heidelberg University have demonstrated this through their methodology for acoustic manipulation. ]]></description>
      <pubDate>Tue, 14 Jul 2026 19:46:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/steering-formulation-engineered-tissue-sound-waves</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/steering-formulation-engineered-tissue-sound-waves</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>University of Hohenheim awarded European University status</title>
      <description><![CDATA[The University of Hohenheim becomes a European University through the EuroLeague of Life Sciences Universities. For ELLS, which is celebrating its 25th anniversary this year, this marks the beginning of a new chapter. The decision will provide students, researchers and staff at the University of Hohenheim in Stuttgart with increased opportunities to study, work and collaborate with partner universities across Europe.]]></description>
      <pubDate>Fri, 10 Jul 2026 14:02:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-hohenheim-awarded-european-university-status</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-hohenheim-awarded-european-university-status</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>DKFZ Innovation Award and DKFZ Patient Expert Award Presented</title>
      <description><![CDATA[The Friends of the German Cancer Research Center (DKFZ) support the DKFZ and aim to help strengthen its position in the international arena. With the DKFZ Innovation Award, presented at this year’s annual reception, the association honors Helmut Salih, a researcher whose innovative work bridges the gap between immunological research and patient care.]]></description>
      <pubDate>Thu, 09 Jul 2026 13:43:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-innovation-award-and-dkfz-patient-expert-award-presented</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-innovation-award-and-dkfz-patient-expert-award-presented</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The University of Freiburg joins the European ELIAS network for sustainable AI</title>
      <description><![CDATA[The University of Freiburg is strengthening its European collaboration in the field of Artificial Intelligence by having been accepted into the Virtual Centre of Excellence of the European AI initiative ELIAS. The Freiburg researchers contribute their expertise to the European network in areas including machine learning, computer vision, robot learning, automated reasoning, intelligent systems and neurotechnologies, as well as responsible AI. ]]></description>
      <pubDate>Thu, 09 Jul 2026 13:20:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-freiburg-joins-european-elias-network-sustainable-ai</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-freiburg-joins-european-elias-network-sustainable-ai</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Coaching for Robots: Jens Kober brings people and machines together</title>
      <description><![CDATA[Robots that can learn and adapt require not only data, AI tools, and algorithms but also direct communication with their users. Jens Kober would like to improve this interaction and as the new head of a research team at Fraunhofer IPA, he is focusing in particular on construction robotics.]]></description>
      <pubDate>Wed, 08 Jul 2026 14:35:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/coaching-robots-jens-kober-brings-people-and-machines-together</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/coaching-robots-jens-kober-brings-people-and-machines-together</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Polyomaviruses: new approaches to prevention and treatment</title>
      <description><![CDATA[In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease. Now, an international research team looking at the viral capsid has identified binding sites for neutralizing antibodies; these sites could be used to halt infection with JC polyomaviruses.]]></description>
      <pubDate>Tue, 07 Jul 2026 12:09:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/polyomaviruses-new-approaches-prevention-and-treatment</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/polyomaviruses-new-approaches-prevention-and-treatment</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Prime Vector Technologies GmbH announces a license agreement with Boehringer Ingelheim to advance next generation cancer vaccine therapies</title>
      <description><![CDATA[Prime Vector Technologies GmbH (PVT), a clinical-stage biotechnology company focusing on the development of viral vector-based vaccines, today announced that it has entered into an agreement with Boehringer Ingelheim for the assignment of certain patents and the exclusive licensing of its Orf virus (ORFV) platform for the development of next-generation cancer vaccines.]]></description>
      <pubDate>Tue, 07 Jul 2026 11:57:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/prime-vector-technologies-gmbh-announces-license-agreement-boehringer-ingelheim-advance-next-generation-cancer-vaccine-therapies</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/prime-vector-technologies-gmbh-announces-license-agreement-boehringer-ingelheim-advance-next-generation-cancer-vaccine-therapies</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New AI System Provides Treatment Recommendations for Complex Blood Cancers</title>
      <description><![CDATA[Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute, and the Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has shown a high degree of agreement with the recommendations of experienced experts and could significantly improve access to specialized and personalized cancer care.]]></description>
      <pubDate>Mon, 06 Jul 2026 09:42:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-ai-system-provides-treatment-recommendations-complex-blood-cancers</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-ai-system-provides-treatment-recommendations-complex-blood-cancers</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Vaccine Against Brain Tumors Shows Promising Long-Term Results</title>
      <description><![CDATA[A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center, Mannheim University Medical Center, Heidelberg University Hospital, and numerous partner institutions* have published encouraging long-term results from a clinical trial involving a vaccine that activates the immune system against a common genetic mutation in these tumors.]]></description>
      <pubDate>Fri, 03 Jul 2026 14:00:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/vaccine-against-brain-tumors-shows-promising-long-term-results</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/vaccine-against-brain-tumors-shows-promising-long-term-results</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>How Tumors Evade Immunotherapy - and How to Prevent It</title>
      <description><![CDATA[Researchers at the German Cancer Research Center (DKFZ) have identified a previously unknown key mechanism by which cancer cells suppress the immune system and thus evade the effects of immunotherapies. At the same time, the new study in mouse models and human tumor samples points to a promising way to prevent resistance to immunotherapy.]]></description>
      <pubDate>Thu, 02 Jul 2026 13:51:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-tumors-evade-immunotherapy-and-how-prevent-it</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-tumors-evade-immunotherapy-and-how-prevent-it</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Virus influences rare brain lymphomas</title>
      <description><![CDATA[Primary CNS lymphomas in immunocompromised patients are among the rarest and at the same time most aggressive cancers – yet evidence-based recommendations for their diagnosis and treatment have been lacking. An international research team led by the Heidelberg Faculty of Medicine at Heidelberg University and the German Cancer Research Center has now identified characteristic imaging features of these tumors and developed a prognostic model.]]></description>
      <pubDate>Thu, 02 Jul 2026 08:52:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/virus-influences-rare-brain-lymphomas</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/virus-influences-rare-brain-lymphomas</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Microbial heritage against stress Study points to cross-generational protection provided by an environmental bacterium</title>
      <description><![CDATA[An environmental bacterium could protect against the effects of stress right through to the next generation. Evidence of this emerged in a study using a mouse model carried out by researchers from Ulm and Frankfurt, the results of which were published in the journal `Molecular Psychiatry´. According to the study, the offspring of treated mothers were better protected against the effects of stress in adulthood than control animals.]]></description>
      <pubDate>Thu, 02 Jul 2026 08:16:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/microbial-heritage-against-stress-study-points-cross-generational-protection-provided-environmental-bacterium</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/microbial-heritage-against-stress-study-points-cross-generational-protection-provided-environmental-bacterium</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>EU-Funded Research Project on Pancreatic Cancer: Heidelberg University Hospital Takes Leading Role in Major EU-Funded Pancreatic Cancer Initiative</title>
      <description><![CDATA[The European Union is funding the PALACROS project with nearly €10 million under its “Horizon Europe” research programme. Researchers from Heidelberg University Hospital and Heidelberg University are helping shape the European PALACROS consortium, developing new standards for the treatment of locally advanced pancreatic cancer.]]></description>
      <pubDate>Wed, 01 Jul 2026 13:17:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-funded-research-project-pancreatic-cancer-heidelberg-university-hospital-takes-leading-role-major-eu-funded-pancreatic-cancer</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-funded-research-project-pancreatic-cancer-heidelberg-university-hospital-takes-leading-role-major-eu-funded-pancreatic-cancer</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Hahn-Schickard Becomes a gGmbH – Karl-Peter Fritz Is the New Managing Director</title>
      <description><![CDATA[Effective July 1, the Hahn-Schickard Association for Applied Research e.V. will spin off its operational business and transfer it to the newly founded Hahn-Schickard gGmbH. This nonprofit company has assumed the universal legal succession of the association and has been entered in the commercial register of the Stuttgart District Court. It is legally represented by its managing director, Dr. Karl-Peter Fritz.]]></description>
      <pubDate>Wed, 01 Jul 2026 12:02:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/hahn-schickard-becomes-ggmbh-karl-peter-fritz-new-managing-director</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/hahn-schickard-becomes-ggmbh-karl-peter-fritz-new-managing-director</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Double ERC Success for DKFZ Researchers</title>
      <description><![CDATA[Through its “Proof of Concept” (PoC) grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research findings. In 2026, two scientists from the German Cancer Research Center (DKFZ) were once again selected to receive this prestigious funding: Moritz Mall and Chong Sun.]]></description>
      <pubDate>Wed, 01 Jul 2026 11:05:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/double-erc-success-dkfz-researchers</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/double-erc-success-dkfz-researchers</guid>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
